fbpx
QQQ
+ 0.56
283.62
+ 0.2%
DIA
-0.40
284.13
-0.14%
SPY
+ 0.98
343.66
+ 0.28%
TLT
+ 0.96
156.09
+ 0.61%
GLD
-0.17
179.00
-0.1%

Benzinga Cannabis Capital Conference And The CBD Show Announce Partnership To Further Promote Cannabis Events

September 23, 2020 11:52 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

Benzinga is excited to announce a partnership with the CBD Show for our virtual Cannabis Capital Conference. This partnership will help both organizations attract wider audiences for their exclusive events.

The Benzinga Cannabis Capital Conference, the premier gathering for investors and entrepreneurs in the cannabis industry, brings together hundreds of cannabis traders, investors, entrepreneurs, and influencers to discuss the present and future landscape of this evolving industry. Attendees enjoy exclusive access to curated networking and private deal flow, as well as hear from executives of top-performing cannabis companies leading the way in growth and innovation.

The CBD Show is an international CBD event, showcasing the best in professional products and services catered to cannabis users and enthusiasts. This partnership exemplifies Benzinga’s dedication to creating positive connections in the cannabis industry and helping to drive the cannabis industry forward for entrepreneurs, investors, company leaders, consumers, and enthusiasts alike.

The final Cannabis Capital Conference of 2020 will take place virtually on October 15th. Confirmed speakers include representatives from Canopy Growth (NYSE:CGC), Cresco Labs (OTCQX:CRLBF), and Trulieve Cannabis (OTCQX:TCNNF), plus many more. Presentations will focus on topics like how to stay socially responsible while investing, how to master brand development in the industry, how companies are navigating the COVID-19 pandemic, and everything you need to know about investing in cannabis.

The CBD Show is set to take place at the Olympia London in London, England from January 29-31st, 2021. Attendees will enjoy three full days of keynotes, seminar talks, and specialized workshops to further knowledge of the CBD industry as well as the ability to network with leading companies in industries like beauty care, nutraceuticals, specialty beverages, functional foods, cultivators, law, branding, and pharmaceuticals.

To learn more about the Benzinga Virtual Cannabis Capital Conference and secure your ticket, click HERE.. For more information on the CBD Show, please click HERE.

Media Contacts
Benzinga Cannabis Capital Conference
877.440-9464 (ZING)
Sarah Winner | Speaker Relations Director
events@benzinga.com

The CBD Show | The Natural Product Show | RASB Media
+44 (0) 203 0260 3908
Joy Brown | Marketing Manager
sales@rasbmedia.com

 


Related Articles

Centri Business Consulting Moderates Panel On Game-Changing Technology For Cannabis Consumers

This special presentation from Centri Business Consulting comes from Benzinga’s Virtual Cannabis Capital Conference that took place on October 15. read more

Verdemed Gives 3 Reasons Why Latin America Is An Interesting Market For Cannabis Companies

This special presentation Verdemed comes from Benzinga’s Virtual Cannabis Capital Conference that took place on October 15. read more

Business Insights From Curaleaf's Boris Jordan: 'Go With Your First Instinct'

"Once you start to over-analyze stuff, you do mess it up," Boris Jordan, the Executive Chairman of Curaleaf Holdings Inc. (OTCQX: CURLF) and Chief Investment Officer at Measure8, told Benzinga's Jason Raznick. read more

Why Vertically-Integrated 1933 Industries Is Positioned To Outperform

1933 Industries joined a panel of cannabis movers and shakers from across the globe at Benzinga’s Virtual Cannabis Capital Conference on October read more

Do Cannabis Investors Need To Know About The Science Behind The Plant?

“There’s a huge misconception that everything in cannabis is the same, and every company in cannabis is doing the same thing,” says Aras Azadian, CEO of Avicanna (TSX: AVCN) (OTCQX: AVCNF), a Toronto-based cannabinoid and biopharmaceutical company. read more